TGFB1 and Behcet disease: A total of 9 CpG sites were detectable in the TGF-β promoter and the methylation level of CG-2.3.4.5 and CG-10.11 units was significantly up-regulated in active BD patients when compared with controls (P=4.65×10−4, P=2.85×10−4, respectively.